; (H) the reasons youth and young adults use such products; (I) the extent to which youth and young adult electronic cigarette users are nicotine dependent; (J) patterns of youth and young adult electronic cigarette cessation behaviors, including patterns in motivation to quit, quit attempts, successful cessation, and associated factors; and (K) resources youth and young adults are using to quit tobacco use. (2) Conducting research on— (A) the characteristics and nicotine delivery technology of electronic cigarettes and emerging tobacco products; (B) biomarkers of exposure to electronic cigarettes and emerging tobacco products and resulting health impacts from such exposure; and (C) the levels of nicotine in electronic cigarettes and emerging tobacco products. (3) Developing, in collaboration with professional medical organizations, guidance for health care providers, schools, and other entities, as appropriate, on intervening with, and treating, youth and young adults who use electronic cigarettes and other emerging tobacco products, and disseminating such guidance. (4) Identifying promising strategies to— (A) prevent and reduce the use by youth and young adults of electronic cigarettes and emerging tobacco products; (B) identify existing, and develop new, cessation strategies and quit support that are appropriate for youth and young adults; and (C) improve access to, and the delivery of tobacco cessation services for, youth and young adults, including the use of technology-delivered services. (5) Identifying effective messages and communication efforts that prevent initiation of tobacco product use and reduce use, including the use of electronic cigarettes and emerging tobacco products, among youth and young adults. (6) Developing and implementing, in coordination with the Commissioner of Food and Drugs, a campaign, in coordination with the Surgeon General, to reduce tobacco initiation and use by youth and young adults, and to educate the public about— (A) the rapidly evolving tobacco product landscape